Guided Therapeutics, Inc. LightTouch Cervical Scan FDA Trial Indicates Improved Detection of Significant Disease over Pap in Private Office Setting
LAS VEGAS--(BUSINESS WIRE)--The Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) LightTouch™ Cervical Scanner increased detection of significant disease over Pap tests in women seen in a busy private practice setting, according to results of a U.S. Food and Drug Administration (FDA) pivotal clinical trial presented at the American Society for Colposcopy and Cervical Pathology biennial meeting.